Health Care/Hospital

Cognizant to apply generative AI to enhance drug discovery for pharmaceutical clients with NVIDIA BioNeMo

Cognizant's AI and industry expertise, combined with the NVIDIA BioNeMo generative AI platform, create a strong foundation to improve outcomes in the healthcare and life sciences sectors TEANECK, N.J., March 19, 2024 /PRNewswire/ -- Cognizant (NASDAQ: CTSH) is advancing the application of genera...

2024-03-19 12:01 410

Takeda Hospital Group Joins TriNetX Network to Revolutionize Medical Care in Japan

CAMBRIDGE, Mass., March 19, 2024 /PRNewswire/ -- Takeda Hospital Group, a leading healthcare provider inKyoto, Japan Prefecture, has joined the TriNetX, LLC (TriNetX) network. Recognizing the need for tailored treatments based on the distinct genetic and lifestyle factors of Japanese patients, T...

2024-03-19 12:01 408

Breakthrough in Treatment of Cervical High-Grade Squamous Intraepithelial Lesion: Release of Positive Results from Multicenter Phase III Global Clinical Study

* The world's first non-surgical cervical HSIL treatment validated by an international Phase III clinical study with proven efficacy; * The response rate increased by 89.4% compared to the placebo control group, with a low incidence of adverse events; * The China new drug application submiss...

2024-03-19 10:24 561

Waterdrop Launches Groundbreaking X Series Reverse Osmosis System, Redefining Standards for Clean, Healthy, and Sustainable Drinking Water

LOS ANGELES, March 18, 2024 /PRNewswire/ -- Waterdrop, an industry leader in water filtration, is thrilled to announce the launch of its most advanced water filtration system - the Waterdrop X Series Reverse Osmosis System. This state-of-the-art product revolutionizes water purification with c...

2024-03-19 10:07 529

ICP DAS-BMP Secures Pivotal TPU Deals with Medical Materials Leaders in U.S. and Japan, Boosts Product Reliability

HSINCHU, March 19, 2024 /PRNewswire/ -- ICP DAS-BMP dazzled at the prestigious MD&M West Show, where its high-quality medical-grade thermoplastic polyurethane (TPU) garnered orders from top manufacturers in U.S. andJapan. Concurrently, part of the company's TPU products passed the ISO10993-6 test...

2024-03-19 08:56 647

Sanyou Bio and BioGeometry join forces to create a next-generation Antibody Drug Discovery Platform driven by AIGC

SHANGHAI, March 18, 2024 /PRNewswire/ -- Recently, BioGeometry and Sanyou Bio jointly announced the signing of a strategic partnership agreement. BioGeometry is a digital biology pioneer company that specializes in AI-driven protein design and R&D platform. Sanyou Bio is a world-leading high-tec...

2024-03-19 08:00 615

Innovent Announces Primary Endpoint Met in the Second Phase 2 Clinical Trial of IBI302 (anti-VEGF/complement) in Treating Neovascular Age-related Macular Degeneration (nAMD)

ROCKVILLIE, Md. and SUZHOU, China, March 19, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major d...

2024-03-19 08:00 674

Reproductive health experts collaborate in multi-centre study with Gene Solutions to develop next-generation prenatal genetic screening test that predicts for adverse pregnancy complications

SINGAPORE, March 19, 2024 /PRNewswire/ -- Gene Solutions announced a multi-centre research collaboration with leadingOBGYN centres in Vietnam, Singapore, Indonesia, and Philippines on the early prediction of pregnancy complications.  This clinical study involving >10,000 women would be the first ...

2024-03-19 07:01 753

Alma launches a special edition of Soprano Titanium with a breakthrough applicator to boost hair removal treatment speed

The latest edition of the flagship hair removal is recognized as the market's fastest hair removal treatment, according to new research CAESAREA, Israel, March 19, 2024 /PRNewswire/ -- Alma , a Sisram Medical company and a global leader in energy-based medical and aesthe...

2024-03-19 07:00 621

QDOSE® Platform Partnership for Personalised Dosimetry in Radiopharmaceutical Therapy

MELBOURNE, Australia and DRESDEN, Germany, March 19, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has entered into an agreement to commercially partner the QDOSE® dosimetry software platform with ABX-CRO Advanced Pharmaceutical Services...

2024-03-19 05:19 769

Abcam appoints Markus Lusser as new President

CAMBRIDGE, England, March 18, 2024 /PRNewswire/ -- Abcam today announced the appointment ofMarkus Lusser as President. Markus Lusser, President of Abcam   A seasoned Danaher executive, Markus joins Abcam at a pivotal m...

2024-03-18 22:20 1015

Lunit Expands Presence in Europe: to Deliver AI-powered Cancer Screening Solution to France and Portugal

* New supply contract to bring Lunit INSIGHT CXR to TeleDiag in France and Lunit INSIGHT MMG to the Central region branch of the Portuguese League Against Cancer SEOUL, South Korea, March 18, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diag...

2024-03-18 21:00 1009

South Korean Insurtech Carrot has secured BBI (Behavior Based Insurance) solution project of Lippo General Insurance, Indonesia

First Step Towards Becoming a Global Insurtech * South Korean Insurtech, Carrot General Insurance has secured project for developing data platform that encompasses comprehensive risk assessment for policyholders to eventually launch behavior based auto insurance product in Indonesia * With it...

2024-03-18 21:00 1137

WuXi AppTec Revenue Surpassed RMB40 Billion in 2023, and Adjusted Non-IFRS Net Profit Exceeded RMB10 Billion for the First Time

* Revenue Up 2.5% Year-over-Year to RMB40,341 Million; Excluding COVID-19 Commercial Projects, Up 25.6% * Net Profit Attributable to the Owners of the Company[1] Increased 9.0% to RMB9,607 Million; Diluted Earnings per Share (EPS) Increased 14.9% to RMB3.24 * Adjusted Non-IFRS Net Profit Att...

2024-03-18 20:32 1068

Aquedeon Medical Announces First Patient Enrolled in the IDE Study of Duett(TM) Vascular Graft System

SUNNYVALE, Calif., March 18, 2024 /PRNewswire/ -- Aquedeon Medical, Inc., a Silicon Valley pioneering medical device company specializing in novel cardiothoracic solutions, is pleased to announce a significant milestone with initiation of its investigational device exemption (IDE) clinical tri...

2024-03-18 20:00 686

EDAN and GH Labs Collaborate to Develop AI-Enabled Ultrasound Devices

BELLEVUE, Wash., March 18, 2024 /PRNewswire/ -- Edan Instruments, Inc. (300206.SZ), a leading global provider of medical and healthcare solutions, announces a collaboration with Global Health Labs, Inc. (GH Labs) to co-develop AI-enabled ultrasound devices. The ...

2024-03-18 19:45 893

Positive results from Phase II clinical trial (CGZ203 study) of Chiglitazar monotherapy for non-alcoholic steatohepatitis

SHENZHEN, China, March 18, 2024 /PRNewswire/ -- On March 18 2024, Shenzhen chipscreen biosciences Co., Ltd. (hereinafter referred to as "chipscreen biosciences", stock code: 688321. SH) announced that the Phase II clinical trial (CGZ203 study) of chiglitazar monotherapy for non-alcoholic steatoh...

2024-03-18 19:25 867

KeChow Pharma Announces NMPA Approval of Tunlametinib (HL-085) as the First Targeted Therapy for Patients with NRAS Mutated Advanced Melanoma and Previously Treated with PD-1/PD-L1

-- Tunlametinib is poised to be a potential best-in-class MEK inhibitor based on positive data from the pivotal Phase 2 study SHANGHAI, March 18, 2024 /PRNewswire/ -- KeChow Pharma, a commercial-stage pharmaceutical company focused on developing and commercializing differentiated small molecule ...

2024-03-18 18:02 878

Cambrex Nears Completion of 5-year, $100-Million-Dollar Investment Plan, One Year Ahead of Schedule

EAST RUTHERFORD, N.J., March 18, 2024 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), announced today that it is nearing the completion of a 5-year,$100-million-dollar investment strategy, one year ahead of schedule. The project, which adds mo...

2024-03-18 18:00 958

Everest Medicines Strengthens Management Team with Appointments of Chief Medical Officer and Chief Product Officer

SHANGHAI, March 18, 2024 /PRNewswire/ -- Everest Medicines (HKEX: 1952.HK, "Everest," or the "Company"), a biopharmaceutical company focused on the discovery, development, manufacturing and commercialization of innovative medicines and vaccines, today announced that the company has strengthened i...

2024-03-18 09:00 1292
12345 ... 799